Sodium Chloride SODIUM CHLORIDE HENRY SCHEIN, INC. FDA Approved This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. Sodium Chloride Injection, USP, 0.9% is a sterile, nonpyrogenic solution. The osmolarity is 0.300 mOsmol/mL (calculated). Each mL contains: Sodium chloride 9 mg; Water for Injection q.s. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single dose containers. Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment (pH 4.5-7.0). Sodium chloride occurs as colorless cubic crystals or white crystalline powder and has a saline taste. Sodium chloride is freely soluble in water. It is soluble in glycerin and slightly soluble in alcohol. The empirical formula for sodium chloride is NaCl and the molecular weight is 58.44.
FunFoxMeds bottle
Substance Sodium Chloride
Route
INTRAVENOUS
Applications
ANDA088912
Package NDC

Drug Facts

Composition & Profile

Strengths
10 unit 10 ml 0.9 %
Quantities
10 ml
Treats Conditions
Indications And Usage This Parenteral Preparation Is Indicated Only For Diluting Or Dissolving Drugs For Intravenous Intramuscular Or Subcutaneous Injection According To Instructions Of The Manufacturer Of The Drug To Be Administered

Identifiers & Packaging

Container Type BOTTLE
All Product Codes
UNII
451W47IQ8X
Packaging

How Supplied Sodium Chloride Injection, USP, 0.9%, preservative free, is available as follows: Preservative Free. Discard unused portion. Use only if solution is clear and seal intact. Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature] www.fresenius-kabi.com/us 45764F Revised: November 2020 Product repackaged by: Henry Schein, Inc., Bastian, VA 24314 From Original Manufacturer/Distributor's NDC and Unit of Sale To Henry Schein Repackaged Product NDC and Unit of Sale Total Strength/Total Volume (Concentration) per unit NDC 63323-186-10 Unit of 25 NDC 0404-9955-10 1 10 mL Single Dose vial in a bag (Vial bears NDC 63323-186-01) 0.9% Image1.jpg; Sample Package Label Label1.jpg

Package Descriptions
  • How Supplied Sodium Chloride Injection, USP, 0.9%, preservative free, is available as follows: Preservative Free. Discard unused portion. Use only if solution is clear and seal intact. Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature] www.fresenius-kabi.com/us 45764F Revised: November 2020 Product repackaged by: Henry Schein, Inc., Bastian, VA 24314 From Original Manufacturer/Distributor's NDC and Unit of Sale To Henry Schein Repackaged Product NDC and Unit of Sale Total Strength/Total Volume (Concentration) per unit NDC 63323-186-10 Unit of 25 NDC 0404-9955-10 1 10 mL Single Dose vial in a bag (Vial bears NDC 63323-186-01) 0.9% Image1.jpg
  • Sample Package Label Label1.jpg

Overview

This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. Sodium Chloride Injection, USP, 0.9% is a sterile, nonpyrogenic solution. The osmolarity is 0.300 mOsmol/mL (calculated). Each mL contains: Sodium chloride 9 mg; Water for Injection q.s. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single dose containers. Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment (pH 4.5-7.0). Sodium chloride occurs as colorless cubic crystals or white crystalline powder and has a saline taste. Sodium chloride is freely soluble in water. It is soluble in glycerin and slightly soluble in alcohol. The empirical formula for sodium chloride is NaCl and the molecular weight is 58.44.

Indications & Usage

: This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

Dosage & Administration

: The volume of the preparation to be used for diluting or dissolving any drug for injection, is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer. This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

Warnings & Precautions
No warnings available yet.
Adverse Reactions

Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures and, if possible, retrieve and save the remainder of the unused vehicle for examination.


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →